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1. Introduction 
Human polymorphonuclear leukocytes (PMNL) 
exhibit a characteristic burst of oxidative metabolism 
following activation by suitable particles [ 11. This 
burst is associated with the formation of several 
potentially bactericidal metabolites of molecular 
oxygen including superoxide anion, hydrogen per- 
oxide and hydroxyl radical. Phagocytosing PMNL 
also generate electronically excited state(s), as mani- 
fested by the phenomenon of chemiluminescence (CL) 
[2]. It was proposed that relaxation of singlet oxygen 
(to its triplet ground state) and/or relaxation of 
excited carbonyl moieties formed during the respi- 
ratory burst may provide a basis for this phenomenon. 
The formation of singlet oxygen via the myeloper- 
oxidase (MPO)-hydrogen peroxide-halide reaction 
has been demonstrated [3], which is operative in 
phagocytosing PMNL. Moreover, analysis of the CL 
spectra for the MPO-HzOz-halide and PMNL reac- 
tions are reportedly quite similar [4]. 
In our laboratory we have been examining the 
relationship between CL and oxidative metabolism 
in human PMNL through the use of several soluble 
agents known to induce a respiratory burst in these 
cells in the absence of particles. One such agent is the 
divalent cation ionophore A23 187, which has been 
reported to stimulate oxidative metabolism in resting 
neutrophils in a calcium-dependent manner [5,6]. 
This communication describes the calcium-dependent 
induction of CLin resting human PMNL by ionophore 
A23 187 and the ability of this agent to modify 
phagocytosis-associated CL induced by opsonized 
zymosan. 
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2. Materials and methods 
2.1. Ionophore 
The carboxylic acid ionophore A23 187 was the 
generous gift of Dr R. L. Hamill of Eli Lilly and Co., 
Indianapolis. A 4 PM solution of this agent was pre- 
pared immediately prior to use by dissolving 0.1308 mg 
in 20 ~1 dimethyl sulfoxide and then diluting appro- 
priately in Dulbecco’s phosphate buffer solution 
(PBS, Grand Island), pH 7.4, containing 0.1% glucose. 
The final concentration of DMSO was < 0.04% and 
was without effect. 
2.2. Leukocyte isolation 
PMNL were isolated by dextran sedimentation [7] 
from peripheral venous blood obtained from healthy 
adult volunteers. Lysis of residual erythrocytes was 
accomplished by brief (2 min) exposure to 0.83% 
ammonium chloride. The leukocyte pellet was rinsed 
once in PBS and then resuspended in l-2 ml buffer. 
PMNL yields were determined by hemacytometer 
and the suspensions adjusted to 2 X 107/ml. 
2.3. Particle opsonization 
Zymosan A (Sigma Chemical Co., St Louis) 20 mg, 
was suspended in a few ml of 0.9% NaCl and placed 
in a boiling water bath for 30 min. Following centri- 
fugation at 500 X g for 5 min, the zymosan pellet 
was resuspended in 5 ml plasma (previously rendered 
free of cellular debris by centrifugation) and incubated 
at 37°C for 30 min. The opsonized zymosan was washed 
once in PBS and resuspended to 4 mg/ml. 
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2.4. Leukocyte viability 
Cellular integrity of PMNL exposed to ionophore 
A23 187 (1 PM) was assessed by monitoring release of 
the cytoplasmic enzyme lactate dehydrogenase, accord- 
ing to [8]. 
2.5. Chemiluminescence 
CL responses were monitored using a Packard 
ambient temperature liquid scintillation counter 
(Model 2002) operated in the out-of-coincidence 
mode. Gain was set at 100% and the discriminator at 
O-1000. Leukocytes (10’ cells) and PBS were added 
to dark-adapted plastic liquid scintillation vials and 
incubated in a 37°C water bath for 1.5 min under con- 
stant agitation. The vials were individually removed 
from the water bath, blotted gently and background 
CL monitored for 0.5 min intervals. The vials were 
then immediately returned to the water bath until 
the next counting interval. CL responses were initi- 
ated via the addition of either 2 mg opsonized zymo- 
san, A23 187 (1 PM final) or both. CL was then 
monitored at 1,5, 10, 15 and 20 min intervals. All 
vials contained a total reaction volume of 2 ml. 
2.6. Statistical analysis 
Comparisons of peak CL responses were performed 
by paired analysis using a two-tailed t-test. 
3. Results 
Figure 1 depicts the CL responses of human PMNL 
exposed to the calcium ionophore A23 187 and/or 
opsonized zymosan. Addition of the ionophore alone 
to resting PMNL induced a CL response in these cells 
(16 071 + 4275 net counts/OS min, mean + SE for 
5 exp.) at a concentration (1 PM) which was non- 
cytotoxic. The ionophoreinduced CL response was 
considerably less than that observed following addi- 
tion of opsonized zymosan to PMNL. Nevertheless, 
addition of A23 187 and zymosan simultaneously to 
resting PMNL resulted in an augmented response to 
zymosan .
Table 1 shows the effect of deleting calcium ions 
from the external milieu on the peak CL responses 
generated by PMNL exposed to A23 187, opsonized 
zymosan, or A23 187 plus zymosan. The ability .of 
the ionophore to induce CL in resting PMNL was 
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Fig.1. Chemiluminescence responses of human PMNL exposed 
to A23 187, opsonized zymosan, or A23 187 plus zymosan. 
Each point represents the mean value of single determina- 
tions from 5 separate experiments. The final concentrations 
of A23187 and opsonized zymosan are 1 MM and 1 mg/ml, 
respectively. 
significantly impaired when extracellular calcium 
was absent. In contrast, phagocytosis-associated CL 
induced by zymosan alone or zymosan plus A23 187 
did not require extracellular calcium. The inability 
of PMNL to respond to the ionophore alone in 
calcium-free buffer containing magnesium ions 
suggests that magnesium is unable to substitute for 
calcium ions in this reaction. In fact, CL responses 
induced by A23 187 are greater in buffer containing 
calcium alone than in buffer containing calcium and 
magnesium ions (data not shown). This suggests that 
magnesium ions may compete with calcium ions for 
complexation by the ionophore. 
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Table 1 
Influence of extracellular calcium on A23 187- and zymosan-induced CL responses 
Peak CL response (counts/OS min)ayb 
Statistical 
with calcium without calcium 
comparison 
(0.9 mM CaCl,) (0.49 mM MgCl,) 
Ionophore A23187 16 071 + 4275 1906 r 420 p < .oos 
Opsonized zymosan 571933-t 46458 577 018 c 102 531 NS 
A23 187 plus zymosan 
(simultaneously added) 782 005 + 124 169 684277* 93026 NS 
a Mean t standard error, n = 5 
b All values are corrected for background CL 
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4. Discussion 
This resport describes the calcium-dependent induc- 
tion of chemiluminescence in resting human poly- 
morphonuclear leukocytes exposed to the divalent 
cation ionophore A23 187. In addition to inducing a 
CL in resting PMNL, the ionophore was also observed 
to augment phagocytosis-associated CL evoked by 
opsonized zymosan. Earlier studies have demonstrated 
the ability of this agent to stimulate oxidative metab- 
olism in PMNL independently of phagocytosis in a 
calcium-dependent manner [5,6,9]. Another soluble 
agent, phorbol myristate acetate (PMA), was reported 
to stimulate oxidative metabolism and CL in resting 
PMNL [lo]. The ability of soluble agents such as PMA 
and A23 187 to induce respiratory activity and CL 
generation in PMNL independently of phagocytosis 
lends support to the contention that membrane 
perturbation may constitute the primary stimulus 
for metabolic activation of these cells. 
The requirement for extracellular calcium in the 
ionophore-induced CL responses of resting PMNL 
led us to examine the role of extracellular calcium 
in the CL responses of PMNL to other activating 
agents. It was observed that phagocytosis-associated 
CL evoked by zymosan, in contrast to A23 187- 
induced CL, does not require the presence of extra- 
cellular calcium. In further studies (unpublished obser- 
vations) we have also found that PMA-induced CL 
responses are independent of a requirement for extra- 
cellular calcium. It is likely, therefore, that if calcium 
ions are involved in mediating and/or modulating the 
oxidative metabolic activity of PMNL, mobilization 
of intracellular calcium pool(s) rather than influx of 
extracellular calcium may be required. The ability of 
the ionophore to stimulate a respiratory burst in these 
cells could arise from the displacement of intracellular 
(presumably bound) calcium by calcium being trans- 
ported into the cell by the ionophore. The existence 
of an intracellular calcium pool(s) has not been con- 
clusively demonstrated in PMNL to date. However, 
it has recently been reported that PMNL prelabeled 
with 45Ca releases this cation when activated by 
opsonized zymosan and that this efflux paralleled 
release of a granule-associated enzyme, /I-glucuronidase 
[ 111. Clearly, further studies are required to elucidate 
both role of calcium ions in the metabolic responses 
of PMNL and the subcellular location of intracellular 
calcium pool(s). 
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